UHS - Universal Health Services, Inc.
NYSE
->
Healthcare
->
Medical Care Facilities
King of Prussia,
United States
Type: Equity
UHS price evolution
UHS
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Dec 2023 | 30 Oct 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $128.79 | $112.09 | $119.44 | $80.77 |
| Short term investments | ||||
| Net receivables | $2156.81 | $2299.43 | $2238.26 | $2234.34 |
| Inventory | $218.78 | $216.06 | $216.99 | $214.59 |
| Total current assets | $2740.69 | $2870.93 | $2811.35 | $2753 |
| Long term investments | ||||
| Property, plant & equipment | $6760.16 | $6607.01 | $6558.49 | $6530.98 |
| Goodwill & intangible assets | $3942.37 | $3928.12 | $3932.41 | $3912.12 |
| Total noncurrent assets | $11330.73 | $11175.2 | $11156.25 | $11120.47 |
| Total investments | ||||
| Total assets | $14071.43 | $14046.13 | $13967.6 | $13873.47 |
| Current liabilities | ||||
| Accounts payable | $1926.3 | $1830.18 | $613.97 | $1783.46 |
| Deferred revenue | ||||
| Short long term debt | $199.49 | $198.49 | $198.29 | $199.21 |
| Total current liabilities | $2149.21 | $2075.34 | $2013.35 | $1989.82 |
| Long term debt | $4796.31 | $5108.71 | $5168.34 | $4796.07 |
| Total noncurrent liabilities | $5371.42 | $5664.95 | $5757.54 | $5777.17 |
| Total debt | $4995.8 | $5307.2 | $5366.63 | $5383.83 |
| Total liabilities | $7520.62 | $7740.29 | $7770.89 | $7808.56 |
| Shareholders' equity | ||||
| Retained earnings | $6475.89 | $6248.11 | $6139.04 | $6074.5 |
| Other shareholder equity | $8.81 | $7.91 | $9.29 | $6064.91 |
| Total shareholder equity | $6485.37 | $6256.7 | $6149 | $6064.91 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $119.44 | $102.82 | $115.3 | $1224.49 |
| Short term investments | ||||
| Net receivables | $2238.26 | $2017.72 | $1746.63 | $1728.93 |
| Inventory | $216.99 | $218.52 | $206.84 | $190.42 |
| Total current assets | $2811.35 | $2537.34 | $2263.56 | $3281.87 |
| Long term investments | $157.06 | |||
| Property, plant & equipment | $6558.49 | $6373.11 | $6241.75 | $5709.64 |
| Goodwill & intangible assets | $3932.41 | $3909.46 | $3962.62 | $3882.72 |
| Total noncurrent assets | $11156.25 | $10956.85 | $10829.99 | $10195.01 |
| Total investments | ||||
| Total assets | $13967.6 | $13494.19 | $13093.54 | $13476.88 |
| Current liabilities | ||||
| Accounts payable | $613.97 | $636.6 | $658.9 | $570.52 |
| Deferred revenue | ||||
| Short long term debt | $198.29 | $149.22 | $112.89 | $391.79 |
| Total current liabilities | $2013.35 | $1914.42 | $1984.11 | $2481.04 |
| Long term debt | $5168.34 | $4726.53 | $4446.5 | $3802.56 |
| Total noncurrent liabilities | $5757.54 | $5614.42 | $4916.38 | $4593.87 |
| Total debt | $5366.63 | $5271.28 | $4559.4 | $4194.35 |
| Total liabilities | $7770.89 | $7573.61 | $6900.49 | $7074.91 |
| Shareholders' equity | ||||
| Retained earnings | $6139.04 | $5929.54 | $6058.6 | $6268.18 |
| Other shareholder equity | $9.29 | -$9.67 | $30.29 | $48.12 |
| Total shareholder equity | $6149 | $5920.58 | $6089.66 | $6317.15 |
| (in millions $) | 30 Jul 2024 | 1 May 2024 | 31 Dec 2023 | 30 Oct 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3703.55 | $3562.77 | ||
| Cost of revenue | ||||
| Gross Profit | $3703.55 | |||
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1799.01 | |||
| Total operating expenses | $3372.35 | $3277.42 | ||
| Operating income | $331.2 | |||
| Income from continuing operations | ||||
| EBIT | $331.47 | |||
| Income tax expense | $61.5 | $52.5 | ||
| Interest expense | $53.59 | -$53.38 | ||
| Net income | ||||
| Net income | $216.38 | $166.94 | ||
| Income (for common shares) | $216.38 | |||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $14281.98 | $13399.37 | $12642.12 | $11558.9 |
| Cost of revenue | ||||
| Gross Profit | $14281.98 | $13399.37 | $12642.12 | $11558.9 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $7107.48 | $6762.26 | $6163.94 | $5613.1 |
| Total operating expenses | $13106.59 | $12395.82 | $11279.02 | $10200.54 |
| Operating income | $1175.38 | $1003.55 | $1363.09 | $1358.35 |
| Income from continuing operations | ||||
| EBIT | $1145.59 | $1011.78 | $1380.94 | $1349.53 |
| Income tax expense | $221.12 | $209.28 | $305.68 | $299.29 |
| Interest expense | $206.67 | $126.89 | $83.67 | $106.28 |
| Net income | ||||
| Net income | $717.79 | $675.61 | $991.59 | $943.95 |
| Income (for common shares) | $717.79 | $675.61 | $991.59 | $943.95 |
| (in millions $) | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 | 30 Oct 2023 |
|---|---|---|---|---|
| Net income | $289.15 | $261.83 | $216.38 | |
| Operating activities | ||||
| Depreciation | $147.48 | $141 | $145.48 | |
| Business acquisitions & disposals | $0.04 | $5.58 | $0.5 | |
| Stock-based compensation | $26.53 | $19.63 | $22.02 | |
| Total cash flows from operations | $679.28 | $396.41 | $452.43 | |
| Investing activities | ||||
| Capital expenditures | -$241.39 | -$208.54 | -$206.39 | |
| Investments | -$1.49 | $8.32 | -$32.97 | |
| Total cash flows from investing | -$242.84 | -$194.64 | -$238.85 | -$524.43 |
| Financing activities | ||||
| Dividends paid | -$13.4 | -$13.6 | -$13.52 | -$41.96 |
| Sale and purchase of stock | -$91.92 | -$138.84 | -$158.21 | |
| Net borrowings | -$318.77 | -$51.87 | -$11.37 | |
| Total cash flows from financing | -$419.52 | -$208.95 | -$182.32 | -$311.63 |
| Effect of exchange rate | $0.1 | -$0.49 | $2.56 | $0.49 |
| Change in cash and equivalents | $17.02 | -$7.67 | $33.83 | -$20.2 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $717.79 | $675.61 | $991.59 | $943.95 |
| Operating activities | ||||
| Depreciation | $568.04 | $581.86 | $533.21 | $510.49 |
| Business acquisitions & disposals | $20.46 | -$8.31 | -$60.26 | -$49.41 |
| Stock-based compensation | $87.72 | $85.38 | $73.69 | $65.84 |
| Total cash flows from operations | $1267.8 | $996.02 | $883.7 | $2360.17 |
| Investing activities | ||||
| Capital expenditures | -$743.05 | -$734 | -$855.66 | -$731.31 |
| Investments | -$40.7 | $94.91 | $1.36 | -$21.74 |
| Total cash flows from investing | -$763.27 | -$647.3 | -$914.47 | -$802.56 |
| Financing activities | ||||
| Dividends paid | -$55.48 | -$58.45 | -$65.9 | -$17.34 |
| Sale and purchase of stock | -$533.71 | -$818.85 | -$1207.5 | -$194.4 |
| Net borrowings | $99.62 | $615.95 | $217.11 | -$160.97 |
| Total cash flows from financing | -$493.94 | -$318.4 | -$1068.95 | -$384.86 |
| Effect of exchange rate | $3.06 | -$8.42 | -$0.5 | $0.74 |
| Change in cash and equivalents | $13.63 | $21.9 | -$1100.22 | $1173.49 |
News
Fundamentals
| Market cap | $15.62B |
|---|---|
| Enterprise value | $20.49B |
| Shares outstanding | 66.71M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 2.41 |
| Book/Share | 97.08 |
| Cash/Share | 1.93 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.26 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.28 |
| Quick ratio | 1.17 |